The specs comparison that doesn’t answer your actual question
You’ve probably already read a device comparison article. Ultherapy targets the SMAS layer at 4.5mm depth; Thermage delivers bulk radiofrequency to the dermis; Oligio uses a broader HIFU spread for overall firming. The mechanisms are real, the distinctions are clinically meaningful, and that information is available in detail at Lifting Devices Compared.
But knowing how the devices work doesn’t answer the question most patients are actually asking: which one is right for me?
That question isn’t really about devices. It’s about faces — specifically, about what kind of structural change is driving what you see in the mirror. A device comparison article describes the tools. This one tries to describe the decision.
Why the same device gives different results on different people
Before the framework, a premise: lifting devices are not universally effective. Each one performs well within a specific indication and underperforms outside of it.
The reason two patients can have Ultherapy at the same clinic with the same operator and come away with very different outcomes is not that one procedure was done better than the other. It is that one patient’s anatomy was a closer match to what that device does well.
This is not a comforting fact if you’ve already bought into the idea that the right device, correctly applied, produces predictable results. The less comfortable truth is that the device is only one variable. The patient’s skin thickness, the depth of their structural laxity, their age-related collagen quality, and the cause of their visible aging all determine what a device can and cannot accomplish.
This is the starting point at Tune Clinic. Before we discuss Ultherapy versus Thermage, we discuss what is actually causing the problem. The device follows from that answer — not the other way around. The principles behind this approach are part of what we describe as the Chamaka-se design method: anatomy first, devices second.
What is the question about skin thickness trying to answer?
Skin thickness is one of the variables that matters most and gets discussed least in patient-facing content.
Thin skin — skin that shows fine surface lines easily, where the underlying structure is visible through the surface — responds differently to energy-based treatments than thicker skin. For Ultherapy specifically, the collagen response to thermal coagulation points at 3.0mm or 1.5mm depth requires a dermal substrate with enough cellular density to mount that response. Patients with very thin, dehydrated, or significantly photodamaged skin may find that Ultherapy at the dermal transducer depths underperforms their expectations, even when the SMAS-level work is technically well executed.
Thermage, which heats the dermis broadly through radiofrequency, may suit thinner skin better in some cases — particularly when the primary complaint is surface laxity and texture rather than deep structural descent.
Thick skin, more common in younger patients and some Asian skin phenotypes, tends to respond well to high-intensity energy. It has more dermal substrate, better collagen repair capacity, and a stronger immediate contraction response. For these patients, Ultherapy’s precision depth targeting often produces a more anatomically specific result than the broader spread of Thermage.
The practical implication: if your skin is thin, tell your physician. It changes the protocol.
How does the pattern of sagging point toward a device?
This is the most clinically useful frame for matching device to anatomy.
Jawline and submental laxity — the blunting of the mandibular angle, jowl formation, or loose skin under the chin — points toward the SMAS as a key component of the problem. The SMAS is the fibromuscular layer that connects superficial facial structures to deeper ones; when it loses tension, the overlying soft tissue descends. Ultherapy at 4.5mm depth targets this layer directly. This is the scenario where Ultherapy has the most compelling evidence base and, in clinical practice, the most consistent outcomes.
Mid-face descent — the flattening of the cheek, the deepening of the nasolabial fold, the loss of the anterior cheek convexity — is a more complex picture. It often involves volume redistribution and ligamentous laxity together. Energy-based lifting addresses the laxity component but cannot replace lost volume; these patients may need a combined approach that includes lifting and some form of volume restoration.
Diffuse skin laxity without deep sagging — skin that has lost its elasticity and no longer “snaps back,” producing a soft, somewhat deflated look without true architectural descent — tends to respond well to Thermage’s bulk dermal heating. The collagen remodeling from radiofrequency suits this pattern better than the focal coagulation point approach of Ultherapy.
Neck and décolletage — the neck skin is thinner than the face and responds to treatment differently. Both Ultherapy and Thermage can address neck laxity; the choice depends on whether the dominant issue is platysmal banding (a muscle problem), skin laxity (a dermal problem), or true submental sag (a structural problem). These are not the same condition.
How does age change the decision?
Age is not a contraindication to any of these devices, but it does shift the calculus.
Patients in their mid-30s to early 40s who are presenting with early structural changes — the first softening of the jawline, a slight heaviness developing under the chin, brow descent that wasn’t there five years ago — are often the best candidates for Ultherapy. The SMAS still has integrity; there is enough collagen substrate to mount a meaningful response; and the correction required is relatively small. These patients tend to produce the most gratifying Ultherapy outcomes, partly because the structural architecture is still in a condition that can respond to thermal stimulus.
Patients in their late 40s to 50s with more established laxity face a different decision. Ultherapy can still produce meaningful improvement, but the expectations need to be calibrated carefully. A patient with moderate jowling and significant skin laxity who expects Ultherapy to restore their face to its 38-year-old state will be disappointed. Used correctly, Ultherapy in this group produces real, measurable structural improvement — but not the magnitude of surgical correction. For patients with significant laxity at multiple levels, a combined approach — such as our Structural Reset protocol that pairs Ultherapy with Thermage under IV sedation — is often more appropriate than either device alone.
Patients in their 60s and beyond present a different set of variables. Skin thinning is typically more pronounced, collagen repair capacity is reduced, and the cause of visible aging is often more complex than any single device can address. Energy-based devices remain useful in this group, but they are more likely to be part of a larger treatment plan than the sole approach.
What about downtime and pain tolerance?
Honest answer: both Ultherapy and Thermage involve discomfort. The quality of that discomfort differs.
Ultherapy at the 4.5mm SMAS depth produces an acute, point-specific sensation — most patients describe it as a brief, sharp electrical feeling at each shot delivery. For some patients, particularly those with thin skin over bony prominences, this is genuinely uncomfortable. Good pain management — topical anesthesia, nerve block options, or for the right patients, IV sedation — makes a meaningful difference and should be discussed before treatment, not during it.
Thermage produces more of a sustained warm-to-hot sensation across the treated area. Many patients find it more tolerable per unit time, but it is a longer session. The subjective experience is “burning pressure” rather than “sharp point.”
Oligio sits between the two in typical patient experience descriptions — broader energy delivery than Ultherapy’s point-specific shots, without the extended duration of Thermage.
Downtime for all three is generally minimal in the sense that there is no formal recovery period. Most patients can resume normal activity the next day. But “minimal downtime” doesn’t mean “undetectable” — redness, mild swelling, and temporary sensitivity are common in the first 48–72 hours, and for patients flying home within days of treatment, this is worth factoring into the schedule.
Where is Oligio’s specific advantage?
Oligio tends to be the choice in two scenarios that don’t obviously favor either Ultherapy or Thermage.
First: patients who need overall facial firming and mild lifting across multiple zones, without a dominant structural problem in a single area. Oligio’s broader energy spread makes it efficient for this kind of broad-coverage work. It is not as precise as Ultherapy for a specific anatomical target, but for patients whose concern is “generally less firm than two years ago,” precision is less important than coverage.
Second: patients with significant pain sensitivity who need SMAS-level depth but cannot or prefer not to undergo Ultherapy’s shot-by-shot intensity. Oligio at HIFU depths is typically described as more comfortable per session, though this varies by individual.
The full breakdown of device characteristics, target depths, and clinical evidence is covered in Korean Lifting Guide and the direct comparison at Ultherapy vs Thermage.
How should I think about combination protocols?
The concept of a combination protocol — Ultherapy plus Thermage, for example — is intuitive once you understand what each device does: SMAS-level structural lift at depth, paired with dermal tightening and collagen remodeling at the surface. The layers work differently, and addressing both produces a more complete result than either alone.
At Tune Clinic, the decision to combine devices is not automatic. It is based on whether the patient’s anatomy genuinely presents problems at multiple layers. A patient whose dominant issue is SMAS laxity and whose skin quality is still good does not necessarily need Thermage. A patient whose dominant issue is surface laxity with intact deep structure does not necessarily need Ultherapy. Recommending the combination when only one layer is clinically necessary is a way of billing for more work, not doing better work.
When combination is genuinely indicated, sequencing matters. The structural layer — SMAS — is addressed first. The dermal layer second. The reason is practical: if the deeper correction is done after the surface work, the two responses may not compound effectively.
Is there a straightforward decision guide?
With the caveats above, a rough framework:
| Clinical picture | First consideration | Notes |
|---|---|---|
| Early jawline softening, intact skin quality, late 30s–40s | Ultherapy | Strong SMAS target, good substrate for response |
| Diffuse skin laxity, no prominent structural sag | Thermage FLX | Dermal remodeling first |
| Broad firming needed, pain-sensitive patient | Oligio | Broad coverage, moderate HIFU depth |
| Multi-layer laxity, mid-to-late 40s+ | Ultherapy + Thermage | Depth first, surface second |
| Significant laxity + skin quality concerns | Structural Reset | Combo under sedation, individualized |
| Volume loss presenting as “sagging” | Neither lifting device alone | Volume restoration is primary |
Use this table carefully. It describes tendencies, not rules. Any cell in it could be wrong for your specific anatomy.
Does the device matter less than it seems?
After all the above: yes.
The device is the medium. The protocol — shot count, depth selection, zone coverage, sequencing — is the design. And behind the protocol is the physician’s assessment of your specific face. The same Ultherapy device operated by two different physicians will produce two different results not because the machine changed but because the protocol design changed.
This is the premise behind How to Choose the Right Lifting Treatment, and it is why the most useful thing you can do before booking any of these devices is not more research on the device — it is a proper consultation with someone who will examine your face and explain to you specifically why they’re recommending what they’re recommending.
For the underlying clinical data comparing the two main device categories, the PubMed literature on microfocused ultrasound versus radiofrequency for facial laxity provides a useful scientific reference point. And for the argument that lifting comparisons often fail patients before they’ve even arrived at a clinic, Why Lifting Comparisons Are Misleading is worth reading alongside this one.
This article is intended for educational purposes for patients researching lifting treatments abroad. Device recommendations depend entirely on individual clinical assessment. Please seek direct physician consultation before making any treatment decision.
